风险提示：股市有风险，投资需谨慎。 来源:金融界 从资金流向来看，8月12日主力资金净流入2.5亿元，近五个交易日累计净流入2.71亿元。 截至2025年8月12日收盘，创新医疗股价报20.59元，较前一交易日上涨1.87元。该股开盘价为18.15元， 最高触及20.59元，最低18.15元，成交量为159.7万手，成交金额31.6亿元。 创新医疗属于医疗服务行业，公司主营业务涵盖医疗健康服务等领域。根据8月9日发布的半年报显示， 公司上半年实现营业总收入4.02亿元，净利润为-0.11亿元，较上年同期增长29.12%。 ...

创新医疗今日涨停，全天换手率38.36%，成交额31.60亿元，振幅13.44%。龙虎榜数据显示，机构净买 入6431.78万元，营业部席位合计净卖出61.37万元。 深交所公开信息显示，当日该股因日涨幅偏离值达9.67%、日换手率达38.36%上榜，机构专用席位净买 入6431.78万元。 证券时报·数据宝统计显示，上榜的前五大买卖营业部合计成交7.08亿元，其中，买入成交额为3.86亿 元，卖出成交额为3.22亿元，合计净买入6370.41万元。 具体来看，今日上榜的营业部中，共有2家机构专用席位现身，即买一、买五、卖三，合计买入金额 1.65亿元，卖出金额1.01亿元，合计净买入6431.78万元。 近半年该股累计上榜龙虎榜10次，上榜次日股价平均涨1.45%，上榜后5日平均涨7.55%。 | 买/ | 会员营业部名称 | 买入金额（万 | 卖出金额（万 | | --- | --- | --- | --- | | 卖 | | 元） | 元） | | 买一 | 机构专用 | 11534.86 | 6280.02 | | 买二 | 兴业证券股份有限公司厦门湖里大道证券营业部 | 7105.03 | 146. ...

Market Overview - As of August 12, the Shanghai Composite Index closed at 3665.92 points, up 18.37 points, with a gain of 0.50% [1] - The Shenzhen Component Index closed at 11351.63 points, up 60.21 points, with a gain of 0.53% [1] - The ChiNext Index closed at 2409.40 points, up 29.58 points, with a gain of 1.24% [1] High Turnover Stocks - A total of 123 A-shares had a turnover rate exceeding 20% on August 12 [1] - Notable stocks with high turnover rates include: - C Guangjian Technology (301632) with a turnover rate of 84.59% and a price increase of 418.45% [1] - Beiwai Technology (002148) with a turnover rate of 60.81% and a price increase of 9.99% [1] - Shuangyi Technology (300690) with a turnover rate of 52.00% and a price increase of 7.60% [1] - C Tianfulong (603406) with a turnover rate of 50.03% and a price decrease of 7.03% [1] Additional High Turnover Stocks - Other stocks with significant turnover rates include: - Furi Electronics (600203) with a turnover rate of 48.75% and a price increase of 10.03% [1] - Yutian Guanjia (301173) with a turnover rate of 47.38% and a price increase of 12.11% [1] - Weier Gao (301251) with a turnover rate of 46.11% and a price increase of 3.29% [1] - Hengbao Co., Ltd. (002104) with a turnover rate of 44.10% and a price increase of 10.00% [1] Summary of Turnover Rates - The data indicates a strong interest in certain stocks, with several experiencing significant price movements alongside high turnover rates, suggesting potential trading opportunities in the market [1]

截至8月12日收盘，脑机接口概念上涨2.37%，位居概念板块涨幅第1，板块内，27股上涨，麒盛科技、 创新医疗等涨停，麦澜德、翔宇医疗、诚益通等涨幅居前，分别上涨18.06%、11.02%、6.87%。跌幅居 前的有际华集团、海格通信、荣泰健康等，分别下跌7.37%、2.90%、2.86%。 今日涨跌幅居前的概念板块 | 概念 | 今日涨跌幅（%） | 概念 | 今日涨跌幅（%） | | --- | --- | --- | --- | | 脑机接口 | 2.37 | PEEK材料 | -1.58 | | 光刻机 | 2.26 | 稀土永磁 | -1.53 | | 中国AI 50 | 2.01 | MLOps概念 | -1.39 | | 国家大基金持股 | 1.83 | 动物疫苗 | -1.34 | | 光刻胶 | 1.68 | 重组蛋白 | -1.14 | | 深圳国企改革 | 1.56 | 转基因 | -1.12 | | 牙科医疗 | 1.51 | DRG/DIP | -1.12 | | 液冷服务器 | 1.46 | 细胞免疫治疗 | -1.10 | | 光纤概念 | 1.43 | 培育钻石 | -1.04 ...

| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 300683 | 海特生物 | 50.48 | -8.67% | 15.85万 | 8.11亿 | | 000504 | *ST生物 | 11.91 | -5.02% | 3.61万 | 4301.65万 | | 688710 | 益诺思 | 42.19 | -3.01% | 1.48万 | 6274.17万 | | 688222 | 成都先导 | 22.28 | -2.88% | 1 20.73万 | 4.60亿 | | 301509 | 金凯生松 | 38.46 | -2.83% | 5.59万 | 2.15亿 | | 688238 | 和元生物 | 7.61 | -2.56% | 13.40万 | 1.02亿 | | 301201 | 诚达药业 | 28.83 | -2.47% | 5.98万 | 1.73亿 | | 300149 | 香督医药 | 12.63 | -2.40% | 36.15万 | 4.58亿 | | 688621 | 阳光 ...

序号代码名称最新价涨跌幅主力净流入主力净占比1688041海光信息138.82.133.88亿元5.62%2300002神 州泰岳14.015.93.83亿元12.12%3600353旭光电子15.56.242.76亿元16.7%4300773拉卡拉28.054.72.56亿元 11.58%5002173创新医疗20.599.992.50亿元7.9%6301095广立微82.05.932.03亿元17.3%7000818航锦科技 22.874.241.95亿元11.38%8603019中科曙光69.131.351.94亿元6.85%9300766每日互动40.888.491.88亿元 4.68%10002721金一文化3.914.831.51亿元14.22% 8月12日，DeepSeek概念上涨0.13%，今日主力资金流入2.67亿元，概念股79只上涨，18只下跌。 主力资金净流入居前的分别为海光信息（3.88亿元）、神州泰岳（3.83亿元）、旭光电子（2.76亿 元）、拉卡拉（2.56亿元）、创新医疗（2.5亿元）。 来源：金融界 ...

8月12日，A股全天震荡拉升，市场分化明显，个股逾3100股下跌。全天成交额1.9万亿，较上个交易日 放量约546亿。截至收盘，沪指涨0.50%，深证成指涨0.53%，创业板指涨1.24%，科创50涨近2%。 市场分析认为，这些利好消息影响市场： 第一，今早，中美斯德哥尔摩经贸会谈联合声明发布，双方同意：自2025年8月12日起再次暂停实施 24%的关税90天，同时保留按该行政令规定对这些商品加征的剩余10%的关税。 第二，今天市场上突然传出，DeepSeek-R2的预计发布时间窗口为2025年8月15日至8月30日，但具体日 期尚未官宣。 第三，截至8月11日，沪深两市融资余额实现重要突破，时隔十年再次突破两万亿元大关。 盘面上，市场热点较为杂乱。券商、保险、多元金融等大金融板块强势，国盛金控涨停；芯片产业链集 体爆发，旭光电子涨停；脑机接口等医疗器械板块持续活跃，创新医疗涨停；新疆振兴概念再度拉升， 八一钢铁、北新路桥"三连板"；港口航运异动拉升，南京港涨停；跨境支付概念股尾盘走强，恒宝股份 涨停。此外，燃气、房地产、通信设备、煤炭开采等板块均有所表现。下跌方面，锂等能源金属板块回 调；军工、光伏设备、影 ...

近日，工业和信息化部等七部门印发《关于推动脑机接口产业创新发展的实施意见》，提出，到2027 年，脑机接口关键技术取得突破，初步建立先进的技术体系、产业体系和标准体系。电极、芯片和整机 产品性能达到国际先进水平，脑机接口产品在工业制造、医疗健康、生活消费等加快应用。产业规模不 断壮大，打造2至3个产业发展集聚区，开拓一批新场景、新模式、新业态。到2030年，脑机接口产业创 新能力显著提升，形成安全可靠的产业体系，培育2至3家有全球影响力的领军企业和一批专精特新中小 企业，构建具有国际竞争力的产业生态，综合实力迈入世界前列。 国元证券指出，脑机接口通过在脑与机器之间建立信息通道，实现生物智能与机器智能的协同交互，是 生命科学和信息科学融合发展的前沿技术。当前，脑机接口创新成果持续涌现，产业加速壮大，正孕育 颠覆性突破，已成为科技创新和产业创新深度融合的重要领域。随着脑机接口技术加速发展，产业政策 日趋明晰，已有北京、上海、南京、四川、山东等省区市发布了相关政策，同时一些医疗机构、企业也 加速推进脑机接口的创新技术研发，产业链中上游的技术进步带来下游应用端不断突破，国内脑机接口 公司有望逐步实现商业化应用，并向产 ...

Core Viewpoint - The brain-computer interface (BCI) sector is experiencing significant growth, driven by recent policy support and technological advancements, with several companies in the field seeing substantial stock price increases. Group 1: Company Performance - QiSheng Technology (麒盛科技) saw its stock price rise by 10.01% to 14.40, with a market capitalization of 5.08 billion, focusing on sleep-related technologies and brain-machine interaction [2] - Innovation Medical (创新医疗) increased by 9.99% to 20.59, with a market cap of 8.57 billion, holding a 40% stake in BoLing Brain-Machine Technology, which is developing core BCI technologies [2] - Xiangyu Medical (翔宇医疗) surged by 13.72% to 65.97, with a market cap of 10.56 billion, having completed several key projects in the BCI field and holding numerous patents [2] - Chengpin Technology (诚品通) rose by 8.60% to 23.23, with a market cap of 6.04 billion, collaborating with Tsinghua University on both non-invasive and invasive BCI technologies [2] Group 2: Industry Developments - On August 7, the Ministry of Industry and Information Technology and six other departments released guidelines to promote BCI innovation, aiming for breakthroughs in key technologies by 2027 [3] - The establishment of the Hubei BCI Industry Innovation Development Alliance was announced on August 9, indicating a collaborative effort to advance the sector [3] - The 2025 World Robot Competition showcased non-invasive BCI products for nerve injury treatment, highlighting the practical applications of BCI technology [3] Group 3: Institutional Insights - The guidelines emphasize the establishment of an advanced technology, industry, and standard system for BCI by 2027, with expectations for BCI applications in healthcare, rehabilitation, and skill replacement [4] - BCI technology is positioned at the intersection of life sciences and information sciences, facilitating collaboration between biological and machine intelligence [4] - Various provinces and cities in China are implementing policies to support BCI development, with significant potential for commercialization in healthcare and other sectors [5]

Group 1 - The stock of Innovation Medical has experienced a significant increase, with three limit-up days recorded within six trading days, resulting in a cumulative rise of 39.59% and a turnover rate of 181.05% [2] - As of 10:11, the stock's trading volume reached 97.2046 million shares, with a transaction amount of 1.887 billion yuan and a turnover rate of 23.35% [2] - The latest total market capitalization of the stock in the A-share market is 9.086 billion yuan, with a circulating market value of 8.572 billion yuan [2] Group 2 - The stock has appeared on the Dragon and Tiger list four times due to a daily turnover rate exceeding 20% and a daily price deviation of 7% [2] - Institutional investors have net sold 25.0823 million yuan, while other trading seats collectively net bought 307 million yuan [2] - The company's semi-annual report released on August 9 shows total operating revenue of 402 million yuan for the first half of the year, a year-on-year decrease of 1.60%, and a net profit of -11 million yuan, reflecting a year-on-year increase of 29.12% [2] Group 3 - The stock's daily performance over recent trading days shows fluctuations in both price and turnover rate, with notable increases and decreases in net capital inflow [2] - Specific daily changes include a 6.36% increase on August 11 with a turnover rate of 35.46% and a net capital inflow of 201.3765 million yuan [2] - The stock also experienced a 10.01% increase on August 7, with a net capital inflow of 226.1818 million yuan [2]